EP0959885A4 - Triaryl substituierte imidazole und verfahren zur verwendung - Google Patents

Triaryl substituierte imidazole und verfahren zur verwendung

Info

Publication number
EP0959885A4
EP0959885A4 EP97948327A EP97948327A EP0959885A4 EP 0959885 A4 EP0959885 A4 EP 0959885A4 EP 97948327 A EP97948327 A EP 97948327A EP 97948327 A EP97948327 A EP 97948327A EP 0959885 A4 EP0959885 A4 EP 0959885A4
Authority
EP
European Patent Office
Prior art keywords
methods
substituted imidazoles
triaryl substituted
triaryl
imidazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97948327A
Other languages
English (en)
French (fr)
Other versions
EP0959885A1 (de
Inventor
Linda L Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700559.9A external-priority patent/GB9700559D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0959885A1 publication Critical patent/EP0959885A1/de
Publication of EP0959885A4 publication Critical patent/EP0959885A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
EP97948327A 1996-11-20 1997-11-17 Triaryl substituierte imidazole und verfahren zur verwendung Withdrawn EP0959885A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3146896P 1996-11-20 1996-11-20
US31468P 1996-11-20
GBGB9700559.9A GB9700559D0 (en) 1997-01-13 1997-01-13 Triaryl substituted imidazoles and methods of use
GB9700559 1997-01-13
PCT/US1997/020955 WO1998022108A1 (en) 1996-11-20 1997-11-17 Triaryl substituted imidazoles and methods of use

Publications (2)

Publication Number Publication Date
EP0959885A1 EP0959885A1 (de) 1999-12-01
EP0959885A4 true EP0959885A4 (de) 2002-07-17

Family

ID=26310784

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97948327A Withdrawn EP0959885A4 (de) 1996-11-20 1997-11-17 Triaryl substituierte imidazole und verfahren zur verwendung

Country Status (5)

Country Link
EP (1) EP0959885A4 (de)
JP (1) JP2001504489A (de)
AU (1) AU726311B2 (de)
CA (1) CA2271941A1 (de)
WO (1) WO1998022108A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503949B1 (en) 1999-05-17 2003-01-07 Noro Nordisk A/S Glucagon antagonists/inverse agonists
JP2003520226A (ja) 2000-01-21 2003-07-02 ノバルティス アクチエンゲゼルシャフト ジペプチジルペプチダーゼ−ｉｖ阻害剤および抗糖尿病薬剤を含む組合せ物
US6562807B2 (en) 2000-06-23 2003-05-13 Novo Nordisk A/S Glucagon antagonists/inverse agonists
AU2002223500A1 (en) 2000-11-17 2002-05-27 Novo-Nordisk A/S Glucagon antagonists/inverse agonists
US6706744B2 (en) 2000-11-17 2004-03-16 Novo Nordisk A/S Glucagon antagonists/inverse agonists
US6821960B2 (en) 2000-11-17 2004-11-23 Noyo Nordisk Pharmaceuticals, Inc. Glucagon antagonists/inverse agonists
WO2003024447A1 (en) * 2001-09-20 2003-03-27 Smithkline Beecham Corporation Inhibitors of glycogen synthase kinase-3
CA2463441A1 (en) * 2001-10-12 2003-05-08 Bayer Pharmaceuticals Corporation Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
US6881746B2 (en) 2001-12-03 2005-04-19 Novo Nordick A/S Glucagon antagonists/inverse agonists
US6762318B2 (en) 2001-12-03 2004-07-13 Novo Nordisk A/S Glucagon antagonists
AU2003299791A1 (en) * 2002-12-20 2004-07-22 Bayer Pharmaceuticals Corporation Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
AU2004210127B2 (en) 2003-01-27 2009-10-01 Merck Sharp & Dohme Corp. Substituted pyrazoles, compositions containing such compounds and methods of use
CN1897936A (zh) 2003-12-19 2007-01-17 默克公司 环状胍、含有这种化合物的组合物及其使用方法
ES2306165T3 (es) 2004-06-04 2008-11-01 MERCK & CO., INC. Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso.
CA2572745A1 (en) 2004-07-07 2006-02-16 Teresa Beeson Pyrazole amide derivatives, compositions containing such compounds and methods of use
ATE468853T1 (de) 2004-07-22 2010-06-15 Merck Sharp & Dohme Substituierte pyrazole, derartige verbindungen enthaltende zusammensetzungen und verfahren zu ihrer verwendung
AU2006227435A1 (en) 2005-03-21 2006-09-28 Merck Sharp & Dohme Corp. Substituted aryl and heteroaryl derivatives
US7803951B2 (en) 2005-03-30 2010-09-28 Merck Sharp & Dohme Corp. Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
US7709658B2 (en) 2005-07-26 2010-05-04 Merck Sharp & Dohme Corp. Process for synthesizing a substituted pyrazole
PE20070458A1 (es) 2005-09-14 2007-07-05 Takeda Pharmaceutical Composicion farmaceutica que comprende 2-[[6-(3r)-3-amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-benzonitrilo como inhibidor de dipeptidil peptidasa
TW200745031A (en) 2005-10-13 2007-12-16 Merck & Co Inc Acyl indoles, compositions containing such compounds and methods of use
CA2645639A1 (en) 2006-03-23 2007-10-04 Merck & Co. Inc. Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2007136577A2 (en) 2006-05-16 2007-11-29 Merck & Co., Inc. Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
TW200821284A (en) 2006-10-03 2008-05-16 Merck & Co Inc Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
WO2011097079A1 (en) 2010-02-03 2011-08-11 Takeda Pharmaceutical Company Limited Apoptosis signal-regulating kinase 1 inhibitors
EP3065736B1 (de) 2013-11-04 2018-11-14 Merck Sharp & Dohme Corp. Glucagon-rezeptor-antagonist-verbindungen, zusammensetzungen daraus und verfahren zur verwendung
ES2926931T3 (es) * 2014-02-07 2022-10-31 Agency Science Tech & Res Inhibidores de caseína quinasa 1 basados en azoles 2,4,5-tri-sustituidos como inductores de la cardiomiogénesis
US20180044316A1 (en) * 2015-03-05 2018-02-15 University Of Notre Dame Du Lac Potentiators of beta-lactam antibiotics
US11958828B1 (en) 2023-11-07 2024-04-16 King Faisal University 4,5-bis(4-bromophenyl)-1-hexyl-2-(3-pyridyl)-1H-imidazole as an antimicrobial compound
US11970462B1 (en) 2024-01-03 2024-04-30 King Faisal University Ethyl 3-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]propanoate as an antimicrobial compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929807A (en) * 1971-05-10 1975-12-30 Ciba Geigy Corp 2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
US4430326A (en) * 1981-12-22 1984-02-07 University Patents, Inc. Method of diminishing glucose levels resulting from endogenous glucagon
WO1993014081A1 (en) * 1992-01-13 1993-07-22 Smithkline Beecham Corporation Imidazole derivatives and their use as cytokine inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
US5620999A (en) * 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929807A (en) * 1971-05-10 1975-12-30 Ciba Geigy Corp 2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
US4430326A (en) * 1981-12-22 1984-02-07 University Patents, Inc. Method of diminishing glucose levels resulting from endogenous glucagon
WO1993014081A1 (en) * 1992-01-13 1993-07-22 Smithkline Beecham Corporation Imidazole derivatives and their use as cytokine inhibitors

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ANESTEZIOLOGIIA I REANIMATOLOGIIA. RUSSIA 1996 SEP-OCT, no. 5, September 1996 (1996-09-01), pages 29 - 39, ISSN: 0201-7563 *
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. UNITED STATES 1 FEB 1993, vol. 300, no. 2, 1 February 1993 (1993-02-01), pages 747 - 750, ISSN: 0003-9861 *
DATABASE MEDLINE [online] 1 February 1993 (1993-02-01), UNSON C G ET AL: "The role of histidine-1 in glucagon action.", XP002199270, Database accession no. NLM8382034 *
DATABASE MEDLINE [online] 1996, DEL REY A ET AL: "Metabolic and endocrine effects of interleukin-1 in obese, diabetic Zucker fa/fa rats.", XP002199269, Database accession no. NLM8886749 *
DATABASE MEDLINE [online] September 1996 (1996-09-01), MAYER N A ET AL: "The utilization of nutrient substances during wound healing", XP002199268, Database accession no. NLM9027251 *
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES: OFFICIAL JOURNAL, GERMAN SOCIETY OF ENDOCRINOLOGY [AND] GERMAN DIABETES ASSOCIATION. GERMANY 1996, vol. 104, no. 4, 1996, pages 317 - 326, ISSN: 0947-7349 *
See also references of WO9822108A1 *

Also Published As

Publication number Publication date
JP2001504489A (ja) 2001-04-03
AU5441498A (en) 1998-06-10
WO1998022108A1 (en) 1998-05-28
AU726311B2 (en) 2000-11-02
EP0959885A1 (de) 1999-12-01
CA2271941A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
EP0959885A4 (de) Triaryl substituierte imidazole und verfahren zur verwendung
PL318128A1 (en) Polymer-polyol and method of obtaining polymer-polyols
EP0948257A4 (de) Triaryl-substituierte imidazole, sie enthaltende zusammensetzungen und verfahren zu ihrer verwendung
EP0862478A4 (de) Ein durch strömungausgerichtetes kathetersystem sowie sein gebrauchsverfahren
IL125716A0 (en) Triaryl compounds and their use as antiinflamatory
GB9422571D0 (en) Haemorrihoidal compositions and method of use
PL332378A1 (en) Brush and method of making same
IL128217A0 (en) Phosphatase inhibitors and methods of use thereof
EP0960191A4 (de) Zusammensetzungeen und verfahren zur verwendungen von defensin
AU2389600A (en) Reservoir-and-filter system and method of use
GB2309326B (en) An objectbase of persistent application objects
EP0942957A4 (de) Ätherisches öl und verwendung desselben
PL318452A1 (en) Method of obtaining peroxyperfluoropolyoxyalkylenes
GB2346823B (en) Reamer and method of using the same
PL330400A1 (en) Method of obtaining azacyclohexapeptides
AU3118297A (en) Sok-1 and methods of use
IL127182A0 (en) Method of improving skin condition
PL332077A1 (en) Method of obtaining omepraole
GB9602704D0 (en) Structure of perculator
PL313419A1 (en) Method of obtaining beta-naphtole
EP0954320A4 (de) Derivate von inositolpolyphosphat und methoden zu deren verwendung
PL333977A1 (en) Method of obtaining benzisothiazolyn-3-ones
GB9700559D0 (en) Triaryl substituted imidazoles and methods of use
GB9616563D0 (en) Compounds and methods
PL332075A1 (en) Method of obtaining nizathidine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990621

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020604

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 9/12 B

Ipc: 7A 61P 3/10 B

Ipc: 7A 61P 3/04 B

Ipc: 7A 61K 31/44 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030904